Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $101.51M | $101.81M | $469.47M | $101.94M | $146.85M |
| Total Operating Revenue | $101.51M | $101.81M | $469.47M | $101.94M | $146.85M |
| Cost of Revenue | $63.22M | $58.98M | $213.99M | $43.76M | $73.61M |
| Gross Profit | $38.29M | $42.83M | $255.47M | $58.19M | $73.24M |
| Operating Expense | $50.93M | $48.68M | $196.91M | $52.08M | $46.51M |
| Selling and Admin Expenses | $36.36M | $34.25M | $136.90M | $36.41M | $32.34M |
| -General & Admin Expense | $36.36M | $34.25M | $136.90M | $36.41M | $32.34M |
| Depreciation & Amortization & Depletion | $9.91M | $10.61M | $41.22M | $11.56M | $9.14M |
| Other Operating Expenses | $4.66M | $3.83M | $18.78M | $4.11M | $5.03M |
| Operating Profit | -$12.64M | -$5.85M | $58.57M | $6.11M | $26.73M |
| Net Non-Operating Interest Income (Expense) | -$3.50M | -$3.82M | -$16.29M | -$3.83M | -$4.93M |
| Non-Operating Interest Income | $279,000.00 | $147,000.00 | $602,000.00 | – | – |
| Non-Operating Interest Expense | $3.25M | $3.70M | $14.90M | $4.03M | $4.35M |
| Total Other Finance Costs | $528,000.00 | $274,000.00 | $1.99M | $393,000.00 | $579,000.00 |
| Other Income (Expense) | -$259,000.00 | -$150,000.00 | $1.43M | -$692,000.00 | $2.09M |
| Earnings from Equity Interest | -$244,000.00 | -$121,000.00 | -$450,000.00 | -$163,000.00 | -$248,000.00 |
| Special Income (Charges) | -$15,000.00 | -$29,000.00 | $1.88M | -$529,000.00 | $2.33M |
| -Gain on Sale of Property/Plant/Equipment | -$15,000.00 | $201,000.00 | $2.49M | $79,000.00 | $2.33M |
| Pretax Profit | -$16.40M | -$9.83M | $43.70M | $1.59M | $23.88M |
| Tax | -$1.16M | -$504,000.00 | $1.83M | $1.83M | $0.00 |
| Net Profit | -$15.24M | -$9.32M | $41.87M | -$240,000.00 | $23.88M |
| Profit from Continuing Operations | -$15.24M | -$9.32M | $41.87M | -$240,000.00 | $23.88M |
| Net Income to Parent Company | -$15.24M | -$9.32M | $41.87M | -$240,000.00 | $23.88M |
| Net Income to Common Stockholders | -$15.24M | -$9.32M | $41.87M | -$240,000.00 | $23.88M |
| Basic EPS | -$0.32 | -$0.20 | $0.98 | $0.00 | $0.56 |
| Diluted EPS | -$0.32 | -$0.20 | $0.96 | -$0.01 | $0.55 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Less:Other Special Charges | – | $230,000.00 | $608,000.00 | – | – |
| -Less:Impairment of Capital Assets | – | – | $0.00 | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $468.04M | $448.63M | $408.05M | $408.05M | $409.46M |
| Total Current Assets | $150.00M | $151.10M | $123.39M | $123.39M | $136.55M |
| Cash and Cash Equivalents & Short-Term Investments | $28.98M | $36.78M | $10.07M | $10.07M | $12.66M |
| -Cash and Cash Equivalents | $28.98M | $36.78M | $10.07M | $10.07M | $12.66M |
| Receivables | $14.40M | $9.15M | $13.99M | $13.99M | $24.76M |
| -Accounts Receivable | $14.40M | $9.15M | $13.99M | $13.99M | $24.76M |
| Prepaid Assets | $1.51M | $1.60M | $5.64M | $5.64M | $4.29M |
| Inventory | $99.17M | $95.06M | $88.39M | $88.39M | $72.01M |
| Restricted Cash | $5.95M | $6.59M | $5.30M | $5.30M | $22.82M |
| Total Non-Current Assets | $318.05M | $297.53M | $284.67M | $284.67M | $272.91M |
| Net PPE | $308.06M | $287.15M | $277.78M | $277.78M | $265.98M |
| -Gross PPE | $692.61M | $663.63M | $645.55M | $645.55M | $636.89M |
| -Accumulated Depreciation | -$384.55M | -$376.48M | -$367.78M | -$367.78M | -$370.90M |
| Investments and Advances | $2.28M | $2.53M | $2.65M | $2.65M | $2.71M |
| -Long Term Equity Investment | $2.28M | $2.53M | $2.65M | $2.65M | $2.71M |
| Other Non-Current Assets | $7.71M | $7.85M | $7,000.00 | $7,000.00 | $4.22M |
| Total Liabilities | $277.71M | $243.06M | $248.22M | $248.22M | $263.27M |
| Total Current Liabilities | $208.69M | $190.05M | $152.60M | $152.60M | $207.35M |
| Payables | $35.34M | $24.29M | $16.49M | $16.49M | $27.61M |
| -Accounts Payable | $31.63M | $19.82M | $12.59M | $12.59M | $23.27M |
| -Total Tax Payable | $3.71M | $4.47M | $3.90M | $3.90M | $4.34M |
| Current Accrued Expenses | $21.02M | $22.80M | $17.53M | $17.53M | $9.60M |
| Short-Term Debt and Capital Lease Obligation | $8.22M | $5.59M | $7.41M | $7.41M | $50.09M |
| -Current Capital Lease Obligation | $4.47M | $5.59M | $7.41M | $7.41M | $7.40M |
| Current Provisions | $2.28M | $2.46M | $2.61M | $2.61M | $1.40M |
| Current Deferred Liabilities | $136.46M | $130.17M | $103.34M | $103.34M | $113.24M |
| Total Non-Current Liabilities | $69.02M | $53.01M | $95.62M | $95.62M | $55.93M |
| Long Term Debt and Capital Lease Obligation | $39.49M | $617,000.00 | $31.02M | $31.02M | $3.14M |
| -Long Term Debt | $39.18M | – | $29.68M | $29.68M | – |
| -Long Term Capital Lease Obligation | $310,000.00 | $617,000.00 | $1.34M | $1.34M | $3.14M |
| Non-Current Liabilities | $16.07M | $15.65M | $15.24M | $15.24M | $16.27M |
| Non-Current Deferred Liabilities | $10.17M | $33.48M | $47.55M | $47.55M | $34.36M |
| Other Non-Current Liabilities | $3.30M | $3.27M | $1.81M | $1.81M | $2.16M |
| Total Equity | $190.33M | $205.57M | $159.83M | $159.83M | $146.19M |
| Stockholders' Equity | $190.33M | $205.57M | $159.83M | $159.83M | $146.19M |
| Capital Stock | $471,000.00 | $471,000.00 | $438,000.00 | $438,000.00 | $430,000.00 |
| -Common Stock | $471,000.00 | $471,000.00 | $438,000.00 | $438,000.00 | $430,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $257.99M | $257.99M | $202.96M | $202.96M | $189.09M |
| Retained Earnings | -$68.12M | -$52.89M | -$43.57M | -$43.57M | -$43.33M |
| Other Current Assets | – | $1.93M | – | – | – |
| Non-Current Prepaid Assets | – | – | $4.23M | $4.23M | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$23.89M | $20.50M | $81.13M | $8.16M | $23.20M |
| Net cash flow from continuing operations | -$23.89M | $20.50M | $81.13M | $8.16M | $23.20M |
| Net Income from Continuing Operations | -$15.24M | -$9.32M | $41.87M | -$240,000.00 | $23.88M |
| Gain/Loss from Continuing Operations | $259,000.00 | $150,000.00 | -$1.43M | $692,000.00 | -$2.09M |
| Depreciation & Depletion & Amortization | $10.14M | $10.69M | $41.22M | $11.56M | $9.14M |
| Deferred Tax | -$1.16M | -$504,000.00 | $1.83M | $1.83M | $0.00 |
| Other Non-Cash Items | -$28.56M | -$33.08M | -$88.05M | -$13.80M | -$13.73M |
| Change in Working Capital | $9.27M | $51.42M | $82.16M | $6.73M | $5.40M |
| -Change in Receivables | -$5.24M | $4.84M | $1.45M | $10.77M | -$6.02M |
| -Change in Inventory | -$4.11M | -$6.67M | -$12.60M | -$16.38M | $14.32M |
| -Change in Prepaid Assets | $2.13M | -$2.58M | $1.91M | $720,000.00 | $187,000.00 |
| -Change in Payables and Accrued Expense | $3.10M | $7.43M | -$2.15M | -$4.08M | -$3.14M |
| -Change In Other Working Capital | $13.39M | $48.41M | $93.56M | $15.69M | $53,000.00 |
| Net cash flow from investing | -$26.26M | -$7.48M | -$66.55M | -$24.77M | -$16.88M |
| Net Cash Flow from Continuing Investing Activities | -$26.26M | -$7.48M | -$66.55M | -$24.77M | -$16.88M |
| Capital Expenditure | -$26.26M | -$7.68M | -$69.22M | -$24.94M | -$19.54M |
| Net PPE Purchase and Sale | -$1,000.00 | $201,000.00 | $3.16M | $267,000.00 | $2.73M |
| Financing Cash Flow | $41.72M | $14.98M | -$11.37M | -$3.50M | -$3.20M |
| Net Cash Flow from Continuing Financing Activities | $41.72M | $14.98M | -$11.37M | -$3.50M | -$3.20M |
| Net Issuance Payments Of Debt | $43.54M | -$33.17M | -$20.99M | -$15.81M | -$2.77M |
| Net Common Stock Issuance | -$12,000.00 | $53.97M | $13.51M | $13.51M | $0.00 |
| Net Other Financing Charges | -$1.81M | -$5.82M | -$3.88M | -$1.20M | -$434,000.00 |
| Ending Cash Balance | $34.93M | $43.36M | $15.37M | $15.37M | $35.48M |
| Net Change in Cash | -$8.43M | $27.99M | $3.22M | -$20.11M | $3.11M |
| Beginning Cash Balance | $43.36M | $15.37M | $12.15M | $35.48M | $32.37M |
| Free Cash Flow | -$50.15M | $12.82M | $11.92M | -$16.78M | $3.66M |
| Net Business Purchase and Sale | – | – | -$490,000.00 | -$96,000.00 | -$72,000.00 |
No comments yet — be the first to weigh in on HNRG.